Stories
Slash Boxes
Comments

SoylentNews is people

SoylentNews is powered by your submissions, so send in your scoop. Only 18 submissions in the queue.
posted by cmn32480 on Thursday December 03 2015, @03:11PM   Printer-friendly
from the flashlight-up-your-colon dept.

in gastrointestinal microbiome research, an area rife with new discoveries and opportunities thanks to recent breakthroughs in our understanding of how influential these microbes are to our health, it has until now been very difficult to monitor microbial cells during their travels through mammalian gastrointestinal tracts. Microbial growth rates fluctuate in response to diet, wellness, exercise and the environment, and are affected by inter-organism competition inside the gut. Yet after entering the gut and before exiting, microbes pass through the "dark zone," where they cannot be accessed or analyzed using standard methods and without disrupting observation of natural conditions.

That challenge inspired Cameron Myhrvold, a Hertz graduate fellow at the Wyss Institute and Harvard Medical School and the lead author on the new study, to work with Silver to develop the novel synthetic "mark and recapture" technique known as DCDC.

Using a genetically engineered red-colored fluorescent protein controlled by a gene expression promoter as a visual flag, Myhrvold set out to quite literally mark and recapture E. coli, which are extremely common bacteria found in all mammalian guts. The DCDC strategy -- in which mice were fed the genetically engineered microbes and then their waste collected for analysis -- enabled the team to precisely count the bacterial cell divisions that occurred inside the mice's gastrointestinal tracts. The fluorescing protein "marked" the first generation of E. coli introduced to the gut and therefore allowed the team to calculate the population dynamics by analyzing the proportion of fluorescing cells versus the entire population of cells collected after their "recapture."

For 30-40 years understanding the human genome was considered the Rosetta Stone for human health. Has the study of microbiomes taken its place?


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 1, Insightful) by Anonymous Coward on Thursday December 03 2015, @04:52PM

    by Anonymous Coward on Thursday December 03 2015, @04:52PM (#271435)

    I believe you like this paper, but you certainly was trolling against other quality research. Not every worthy scientific paper has to be groundbreaking. Indeed, without those other 'mundane' papers, this one would never have been written, much less funded.

    Starting Score:    0  points
    Moderation   +1  
       Insightful=1, Total=1
    Extra 'Insightful' Modifier   0  

    Total Score:   1  
  • (Score: 0, Interesting) by Anonymous Coward on Thursday December 03 2015, @05:10PM

    by Anonymous Coward on Thursday December 03 2015, @05:10PM (#271443)

    This should be a mundane paper. The only reason the other 9,999/10,000 are produced is that people don't know what a p-value means so the project is designed to see if one group differs from another. I know, I was trained to be a confused person like them. It's awful to see people waste their lives like that.